Tomoyuki Fujisawa Selected Research

Idiopathic Interstitial Pneumonias

1/2022	Prognostic implication of IgG4 and IgG1-positive cell infiltration in the lung in patients with idiopathic interstitial pneumonia.
4/2021	Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia.
1/2021	Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
11/2020	Clinical, radiological, and pathological evaluation of "NSIP with OP overlap" pattern compared with NSIP in patients with idiopathic interstitial pneumonias.
7/2019	Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.
1/2018	Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias.
5/2008	Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomoyuki Fujisawa Research Topics

Disease

26	Idiopathic Pulmonary Fibrosis 01/2022 - 09/2013
18	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 07/2003
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 12/2015
17	Asthma (Bronchial Asthma) 05/2022 - 03/2008
13	Neoplasms (Cancer) 02/2022 - 06/2012
11	Chronic Obstructive Pulmonary Disease (COPD) 05/2022 - 11/2009
11	Disease Progression 01/2022 - 01/2015
9	Inflammation (Inflammations) 01/2022 - 08/2008
8	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2016
8	Dermatomyositis (Dermatopolymyositis) 01/2021 - 01/2015
7	Idiopathic Interstitial Pneumonias 01/2022 - 05/2008
6	Adenocarcinoma of Lung 01/2022 - 01/2017
6	Infections 02/2021 - 01/2005
5	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 06/2008
5	Nausea 01/2019 - 12/2015
4	Fibrosis (Cirrhosis) 01/2021 - 12/2012
4	Pneumonia (Pneumonitis) 02/2020 - 09/2011
4	Sarcoidosis (Schaumann Disease) 11/2019 - 01/2005
4	Vomiting 01/2019 - 12/2015
3	Death (Near-Death Experience) 04/2022 - 11/2020
3	Connective Tissue Diseases (Connective Tissue Disease) 01/2022 - 10/2010
3	Pneumothorax 01/2021 - 01/2020
3	Vascular Diseases (Vascular Disease) 01/2016 - 06/2009
2	Body Weight (Weight, Body) 02/2022 - 12/2021
2	Obesity 01/2022 - 01/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2021
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2022 - 06/2015
2	Myositis (Idiopathic Inflammatory Myopathies) 04/2021 - 12/2016
2	Melanoma (Melanoma, Malignant) 04/2021 - 12/2016
2	Neutropenia 01/2021 - 01/2019
2	Rheumatoid Arthritis 07/2019 - 01/2015
2	Bronchiectasis 01/2018 - 01/2014
2	Airway Obstruction (Choking) 09/2014 - 04/2013
2	Airway Remodeling 09/2014 - 08/2009
2	Hyperplasia 08/2011 - 03/2008
1	Leukopenia 01/2022
1	Adenocarcinoma 01/2022
1	Thrombosis (Thrombus) 01/2022

Drug/Important Bio-Agent (IBA)

12	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021 - 04/2012
10	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 08/2008
8	Biomarkers (Surrogate Marker)IBA 11/2021 - 09/2014
8	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 12/2015
5	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2012
5	AutoantibodiesIBA 01/2022 - 12/2016
5	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 04/2021 - 01/2015
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2017
5	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2016
5	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 01/2014
4	NivolumabIBA 02/2022 - 01/2019
4	Pharmaceutical PreparationsIBA 01/2022 - 11/2004
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 12/2015
4	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2019
4	pirfenidoneIBA 07/2021 - 01/2014
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 05/2008
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 07/2003
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2017
4	Mannose ReceptorIBA 02/2020 - 01/2018
4	AntiemeticsIBA 01/2019 - 12/2015
4	CollagenIBA 01/2016 - 06/2009
3	Oxygen (Dioxygen)IBA 04/2022 - 03/2017
3	LigandsIBA 02/2022 - 06/2012
3	AntibodiesIBA 04/2021 - 01/2015
3	Peroxidase (Myeloperoxidase)IBA 01/2021 - 05/2008
3	Formoterol Fumarate (Oxis)FDA Link 01/2019 - 02/2014
3	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 09/2013
3	Phenobarbital (Luminal)FDA Link 01/2019 - 12/2018
3	Budesonide (Pulmicort)FDA LinkGeneric 01/2019 - 02/2014
3	Interleukin-17 (Interleukin 17)IBA 10/2018 - 01/2014
2	atezolizumabIBA 07/2022 - 01/2022
2	Bronchodilator Agents (Bronchodilators)IBA 05/2022 - 01/2015
2	Serum AlbuminIBA 02/2022 - 12/2021
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2017
2	LipidsIBA 01/2022 - 01/2005
2	PlatinumIBA 12/2021 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2021 - 06/2015
2	Angiopoietin-1IBA 01/2021 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 06/2018
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 01/2015
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2018
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 11/2020 - 10/2010
2	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2019 - 10/2016
2	CytokinesIBA 10/2018 - 01/2014
2	Messenger RNA (mRNA)IBA 10/2018 - 03/2008
2	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 09/2018 - 07/2016
2	Aprepitant (Emend)FDA Link 09/2018 - 12/2015
2	Pemetrexed (MTA)FDA Link 06/2018 - 05/2016
2	Salmeterol Xinafoate (Serevent)FDA Link 01/2018 - 02/2014
2	Fluticasone (Cutivate)FDA LinkGeneric 01/2018 - 02/2014
2	AntigensIBA 01/2018 - 01/2005
2	Polymyxin B (Aerosporin)FDA LinkGeneric 02/2015 - 05/2008
2	Therapeutic UsesIBA 01/2015 - 05/2008
2	MucinsIBA 11/2009 - 03/2008
1	Muscarinic AntagonistsIBA 05/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022

Therapy/Procedure

35	Therapeutics 07/2022 - 06/2009
11	Drug Therapy (Chemotherapy) 01/2022 - 12/2015
2	Artificial Respiration (Mechanical Ventilation) 04/2022 - 06/2008
2	Aftercare (After-Treatment) 01/2022 - 06/2015
2	Palliative Care (Palliative Therapy) 01/2021 - 11/2020
1	Noninvasive Ventilation 04/2022